BioCentury
ARTICLE | Company News

Boehringer settling U.S. Pradaxa litigation

May 29, 2014 1:03 AM UTC

Boehringer Ingelheim GmbH (Ingelheim, Germany) will pay $650 million to settle about 4,000 product liability claims related to Pradaxa dabigatran etexilate. The claims in U.S. state and federal courts...